2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A prominent function of TGIF1 is suppression of transforming growth factor beta ( TGF‐β) signaling, whose inactivation is deemed instrumental to the progression of pancreatic ductal adenocarcinoma ( PDAC), as exemplified by the frequent loss of the tumor suppressor gene SMAD4 in this malignancy. Surprisingly, we found that genetic inactivation of Tgif1 in the context of oncogenic Kras, Kras G12D, culminated in the development of highly aggressive and metastatic PDAC despite de‐repressing TGF‐β signaling. Mechanistic experiments show that TGIF1 associates with Twist1 and inhibits Twist1 expression and activity, and this function is suppressed in the vast majority of human PDACs by Kras G12D/ MAPK‐mediated TGIF1 phosphorylation. Ablating Twist1 in Kras G12D ;Tgif1 KO mice completely blunted PDAC formation, providing the proof‐of‐principle that TGIF1 restrains Kras G12D‐driven PDAC through its ability to antagonize Twist1. Collectively, these findings pinpoint TGIF1 as a potential tumor suppressor in PDAC and further suggest that sustained activation of TGF‐β signaling might act to accelerate PDAC progression rather than to suppress its initiation.

          Related collections

          Author and article information

          Contributors
          azeddine.atfi@inserm.fr
          Journal
          EMBO J
          EMBO J
          10.1002/(ISSN)1460-2075
          EMBJ
          embojnl
          The EMBO Journal
          John Wiley and Sons Inc. (Hoboken )
          0261-4189
          1460-2075
          31 May 2019
          01 July 2019
          : 38
          : 13 ( doiID: 10.1002/embj.v38.13 )
          : e101067
          Affiliations
          [ 1 ] Cellular and Molecular Pathogenesis Division Department of Pathology and Massey Cancer Center Virginia Commonwealth University Richmond VA USA
          [ 2 ] Cancer Institute University of Mississippi Medical Center Jackson MS USA
          [ 3 ] Centre de Recherche Saint‐Antoine, CRSA Inserm Sorbonne Universités Paris France
          [ 4 ] Department of Pathology Lake Erie College of Osteopathic Medicine Erie PA USA
          Author notes
          [*] [* ]Corresponding author. Tel: +1 617 981 2136; E‐mail: azeddine.atfi@ 123456inserm.fr
          Author information
          https://orcid.org/0000-0002-7904-3024
          https://orcid.org/0000-0002-9986-3572
          Article
          PMC6601038 PMC6601038 6601038 EMBJ2018101067
          10.15252/embj.2018101067
          6601038
          31268604
          df69a52a-5d1a-4e28-8d3b-42bfa96cbd3f
          © 2019 The Authors
          History
          : 05 November 2018
          : 11 April 2019
          : 23 April 2019
          Page count
          Figures: 8, Tables: 0, Pages: 19, Words: 12653
          Funding
          Funded by: National Institute of Health
          Award ID: R01AR059070
          Award ID: R01CA210911
          Funded by: U. S. Department of Defense (DOD)
          Award ID: PR162051
          Funded by: Association pour la Recherche sur le Cancer
          Award ID: R11120DD
          Categories
          Article
          Articles
          Custom metadata
          2.0
          embj2018101067
          01 July 2019
          Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.5 mode:remove_FC converted:01.07.2019

          TGIF1,Twist1, TGF‐β signaling,Cancer,pancreatic ductal adenocarcinoma,oncogenic Kras,Transcription

          Comments

          Comment on this article